Andrea Waldman, MD, FAAD, FAAP, is a triple board-certified pediatric dermatologist and a faculty member of the ADCS Orlando Dermatology Residency Program.
Daily Derm Times: May 8, 2025
Switching Gears in Atopic Dermatitis: How Upadacitinib Helps Patients Reach Optimal Targets After Dupilumab Inadequacy
Corvus Pharmaceuticals’ Soquelitinib Shows Rapid, Dose-Dependent Efficacy in Phase 1 AD Trial
Abrocitinib Shows Age-Linked Safety Differences